Selected research
Industry Research
Cholesterol-Lowering Supplements Industry Research Report 2026
Market perspective
The global Cholesterol-Lowering Supplements market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Cholesterol-Lowering Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Cholesterol-Lowering Supplements is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Cholesterol-Lowering Supplements is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Cholesterol-Lowering Supplements include Vitabiotics, TCI Co. Ltd., Streamline Pharma Pvt. Ltd., Step One Foods, Solgar, Pure Encapsulations LLC, ORGANIC INDIA Pvt. Ltd., Inlife Pharma Private Limite and Holland & Barrett, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Cholesterol-Lowering Supplements market in terms of revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cholesterol-Lowering Supplements Market by Company
Vitabiotics
TCI Co. Ltd.
Streamline Pharma Pvt. Ltd.
Step One Foods
Solgar
Pure Encapsulations LLC
ORGANIC INDIA Pvt. Ltd.
Inlife Pharma Private Limite
Holland & Barrett
Himalaya Wellness Company.
HERBAL CREATIONS
Croda International Plc
Cargill
Bioglan
ADM
Cholesterol-Lowering Supplements Segment by Type
Animal-Based
Plant-Based
Others
Cholesterol-Lowering Supplements Segment by Application
Online Sales
Offline Sales
Cholesterol-Lowering Supplements Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cholesterol-Lowering Supplements market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cholesterol-Lowering Supplements and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cholesterol-Lowering Supplements.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Cholesterol-Lowering Supplements manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Cholesterol-Lowering Supplements by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Cholesterol-Lowering Supplements in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Animal-Based
- Plant-Based
- Others
Applications
- Online Sales
- Offline Sales
Companies covered
- Vitabiotics
- TCI Co. Ltd.
- Streamline Pharma Pvt. Ltd.
- Step One Foods
- Solgar
- Pure Encapsulations LLC
- ORGANIC INDIA Pvt. Ltd.
- Inlife Pharma Private Limite
- Holland & Barrett
- Himalaya Wellness Company.
- HERBAL CREATIONS
- Croda International Plc
- Cargill
- Bioglan
- ADM
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Cholesterol-Lowering Supplements Market Size (2021-2032)
- 2.2.2 Global Cholesterol-Lowering Supplements Sales (2021-2032)
- 2.2.3 Global Cholesterol-Lowering Supplements Market Average Price (2021-2032)
- 2.3 Cholesterol-Lowering Supplements by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Animal-Based
- 2.3.3 Plant-Based
- 2.3.4 Others
- 2.4 Cholesterol-Lowering Supplements by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Online Sales
- 2.4.3 Offline Sales
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Cholesterol-Lowering Supplements Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Cholesterol-Lowering Supplements Sales (Tons) of Manufacturers (2021-2026)
- 3.3 Global Cholesterol-Lowering Supplements Revenue of Manufacturers (2021-2026)
- 3.4 Global Cholesterol-Lowering Supplements Average Price by Manufacturers (2021-2026)
- 3.5 Global Cholesterol-Lowering Supplements Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Cholesterol-Lowering Supplements, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Cholesterol-Lowering Supplements, Product Type & Application
- 3.8 Global Manufacturers of Cholesterol-Lowering Supplements, Established Date
- 3.9 Global Cholesterol-Lowering Supplements Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Vitabiotics
- 4.1.1 Vitabiotics Company Information
- 4.1.2 Vitabiotics Business Overview
- 4.1.3 Vitabiotics Cholesterol-Lowering Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Vitabiotics Cholesterol-Lowering Supplements Product Portfolio
- 4.1.5 Vitabiotics Recent Developments
- 4.2 TCI Co. Ltd.
- 4.2.1 TCI Co. Ltd. Company Information
- 4.2.2 TCI Co. Ltd. Business Overview
- 4.2.3 TCI Co. Ltd. Cholesterol-Lowering Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 TCI Co. Ltd. Cholesterol-Lowering Supplements Product Portfolio
- 4.2.5 TCI Co. Ltd. Recent Developments
- 4.3 Streamline Pharma Pvt. Ltd.
- 4.3.1 Streamline Pharma Pvt. Ltd. Company Information
- 4.3.2 Streamline Pharma Pvt. Ltd. Business Overview
- 4.3.3 Streamline Pharma Pvt. Ltd. Cholesterol-Lowering Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Streamline Pharma Pvt. Ltd. Cholesterol-Lowering Supplements Product Portfolio
- 4.3.5 Streamline Pharma Pvt. Ltd. Recent Developments
- 4.4 Step One Foods
- 4.4.1 Step One Foods Company Information
- 4.4.2 Step One Foods Business Overview
- 4.4.3 Step One Foods Cholesterol-Lowering Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Step One Foods Cholesterol-Lowering Supplements Product Portfolio
- 4.4.5 Step One Foods Recent Developments
- 4.5 Solgar
- 4.5.1 Solgar Company Information
- 4.5.2 Solgar Business Overview
- 4.5.3 Solgar Cholesterol-Lowering Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Solgar Cholesterol-Lowering Supplements Product Portfolio
- 4.5.5 Solgar Recent Developments
- 4.6 Pure Encapsulations LLC
- 4.6.1 Pure Encapsulations LLC Company Information
- 4.6.2 Pure Encapsulations LLC Business Overview
- 4.6.3 Pure Encapsulations LLC Cholesterol-Lowering Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Pure Encapsulations LLC Cholesterol-Lowering Supplements Product Portfolio
- 4.6.5 Pure Encapsulations LLC Recent Developments
- 4.7 ORGANIC INDIA Pvt. Ltd.
- 4.7.1 ORGANIC INDIA Pvt. Ltd. Company Information
- 4.7.2 ORGANIC INDIA Pvt. Ltd. Business Overview
- 4.7.3 ORGANIC INDIA Pvt. Ltd. Cholesterol-Lowering Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 ORGANIC INDIA Pvt. Ltd. Cholesterol-Lowering Supplements Product Portfolio
- 4.7.5 ORGANIC INDIA Pvt. Ltd. Recent Developments
- 4.8 Inlife Pharma Private Limite
- 4.8.1 Inlife Pharma Private Limite Company Information
- 4.8.2 Inlife Pharma Private Limite Business Overview
- 4.8.3 Inlife Pharma Private Limite Cholesterol-Lowering Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Inlife Pharma Private Limite Cholesterol-Lowering Supplements Product Portfolio
- 4.8.5 Inlife Pharma Private Limite Recent Developments
- 4.9 Holland & Barrett
- 4.9.1 Holland & Barrett Company Information
- 4.9.2 Holland & Barrett Business Overview
- 4.9.3 Holland & Barrett Cholesterol-Lowering Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Holland & Barrett Cholesterol-Lowering Supplements Product Portfolio
- 4.9.5 Holland & Barrett Recent Developments
- 4.10 Himalaya Wellness Company.
- 4.10.1 Himalaya Wellness Company. Company Information
- 4.10.2 Himalaya Wellness Company. Business Overview
- 4.10.3 Himalaya Wellness Company. Cholesterol-Lowering Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Himalaya Wellness Company. Cholesterol-Lowering Supplements Product Portfolio
- 4.10.5 Himalaya Wellness Company. Recent Developments
- 4.11 HERBAL CREATIONS
- 4.11.1 HERBAL CREATIONS Company Information
- 4.11.2 HERBAL CREATIONS Business Overview
- 4.11.3 HERBAL CREATIONS Cholesterol-Lowering Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 HERBAL CREATIONS Cholesterol-Lowering Supplements Product Portfolio
- 4.11.5 HERBAL CREATIONS Recent Developments
- 4.12 Croda International Plc
- 4.12.1 Croda International Plc Company Information
- 4.12.2 Croda International Plc Business Overview
- 4.12.3 Croda International Plc Cholesterol-Lowering Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Croda International Plc Cholesterol-Lowering Supplements Product Portfolio
- 4.12.5 Croda International Plc Recent Developments
- 4.13 Cargill
- 4.13.1 Cargill Company Information
- 4.13.2 Cargill Business Overview
- 4.13.3 Cargill Cholesterol-Lowering Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Cargill Cholesterol-Lowering Supplements Product Portfolio
- 4.13.5 Cargill Recent Developments
- 4.14 Bioglan
- 4.14.1 Bioglan Company Information
- 4.14.2 Bioglan Business Overview
- 4.14.3 Bioglan Cholesterol-Lowering Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Bioglan Cholesterol-Lowering Supplements Product Portfolio
- 4.14.5 Bioglan Recent Developments
- 4.15 ADM
- 4.15.1 ADM Company Information
- 4.15.2 ADM Business Overview
- 4.15.3 ADM Cholesterol-Lowering Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 ADM Cholesterol-Lowering Supplements Product Portfolio
- 4.15.5 ADM Recent Developments
5 Global Cholesterol-Lowering Supplements Market Scenario by Region
- 5.1 Global Cholesterol-Lowering Supplements Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Cholesterol-Lowering Supplements Sales by Region: 2021-2032
- 5.2.1 Global Cholesterol-Lowering Supplements Sales by Region: 2021-2026
- 5.2.2 Global Cholesterol-Lowering Supplements Sales by Region: 2027-2032
- 5.3 Global Cholesterol-Lowering Supplements Revenue by Region: 2021-2032
- 5.3.1 Global Cholesterol-Lowering Supplements Revenue by Region: 2021-2026
- 5.3.2 Global Cholesterol-Lowering Supplements Revenue by Region: 2027-2032
- 5.4 North America Cholesterol-Lowering Supplements Market Facts & Figures by Country
- 5.4.1 North America Cholesterol-Lowering Supplements Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Cholesterol-Lowering Supplements Sales by Country (2021-2032)
- 5.4.3 North America Cholesterol-Lowering Supplements Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Cholesterol-Lowering Supplements Market Facts & Figures by Country
- 5.5.1 Europe Cholesterol-Lowering Supplements Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Cholesterol-Lowering Supplements Sales by Country (2021-2032)
- 5.5.3 Europe Cholesterol-Lowering Supplements Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Cholesterol-Lowering Supplements Market Facts & Figures by Country
- 5.6.1 Asia Pacific Cholesterol-Lowering Supplements Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Cholesterol-Lowering Supplements Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Cholesterol-Lowering Supplements Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Cholesterol-Lowering Supplements Market Facts & Figures by Country
- 5.7.1 South America Cholesterol-Lowering Supplements Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Cholesterol-Lowering Supplements Sales by Country (2021-2032)
- 5.7.3 South America Cholesterol-Lowering Supplements Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Cholesterol-Lowering Supplements Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Cholesterol-Lowering Supplements Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Cholesterol-Lowering Supplements Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Cholesterol-Lowering Supplements Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Cholesterol-Lowering Supplements Sales by Type (2021-2032)
- 6.1.1 Global Cholesterol-Lowering Supplements Sales by Type (2021-2032) & (Tons)
- 6.1.2 Global Cholesterol-Lowering Supplements Sales Market Share by Type (2021-2032)
- 6.2 Global Cholesterol-Lowering Supplements Revenue by Type (2021-2032)
- 6.2.1 Global Cholesterol-Lowering Supplements Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Cholesterol-Lowering Supplements Revenue Market Share by Type (2021-2032)
- 6.3 Global Cholesterol-Lowering Supplements Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Cholesterol-Lowering Supplements Sales by Application (2021-2032)
- 7.1.1 Global Cholesterol-Lowering Supplements Sales by Application (2021-2032) & (Tons)
- 7.1.2 Global Cholesterol-Lowering Supplements Sales Market Share by Application (2021-2032)
- 7.2 Global Cholesterol-Lowering Supplements Revenue by Application (2021-2032)
- 7.2.1 Global Cholesterol-Lowering Supplements Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Cholesterol-Lowering Supplements Revenue Market Share by Application (2021-2032)
- 7.3 Global Cholesterol-Lowering Supplements Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Cholesterol-Lowering Supplements Value Chain Analysis
- 8.1.1 Cholesterol-Lowering Supplements Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Cholesterol-Lowering Supplements Production Mode & Process
- 8.2 Cholesterol-Lowering Supplements Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Cholesterol-Lowering Supplements Distributors
- 8.2.3 Cholesterol-Lowering Supplements Customers
9 Global Cholesterol-Lowering Supplements Analyzing Market Dynamics
- 9.1 Cholesterol-Lowering Supplements Industry Trends
- 9.2 Cholesterol-Lowering Supplements Industry Drivers
- 9.3 Cholesterol-Lowering Supplements Industry Opportunities and Challenges
- 9.4 Cholesterol-Lowering Supplements Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst